Los puntos clave no están disponibles para este artículo en este momento.
HER2 is an important member of a complex signaling network and when gene amplified, it results in an aggressive subtype of breast cancer. Patients with tumors found to overexpress HER2 protein or to be amplified for the gene are candidates for therapy that significantly reduces mortality.
Gutiérrez et al. (Sat,) studied this question.